Specialty drugs are a relatively small part of total prescriptions filled at the pharmacy, but they are a dramatically increasing part of total prescription spending. A new study from the University of North Carolina at Chapel Hill reveals that just … Read more

When medicine is injected, a little bit stays behind in the syringe. It’s not much, but depending on syringe design and the cost of the drug, this waste — or dead space — can add up to as much as … Read more

Joel Farley, Ph.D., has been promoted to full professor in the Division of Pharmaceutical Outcomes and Policy. Farley joined the UNC Eshelman School of Pharmacy in 2006 as an assistant professor in the department and was named an associate professor … Read more

For advanced liver cancer, there’s a single approved drug shown to offer patients a chance at longer life. But a new study by University of North Carolina at Chapel Hill researchers found that this drug was notably less effective in … Read more

Children receiving a prescription medication should be counseled directly by a health care professional, recommends the Institute of Medicine and United States Pharmacopeia. But that’s not happening, according to a new study led by the UNC Eshelman School of Pharmacy. … Read more

New cancer drugs taken in pill form have become dramatically more expensive in their first year on the market compared with drugs launched 15 years ago, a University of North Carolina at Chapel Hill study has found. The findings call … Read more

The advent of targeted drugs for a specific type of breast cancer – HER2 positive – has dramatically improved survival rates for women with the disease. But a study led by researchers at the University of North Carolina at Chapel … Read more

Research into the safety of pediatric medications is the focus of Chapel Hill PharmSci 2016 hosted by the UNC Eshelman School of Pharmacy May 12-13 and sponsored by the Agency for Healthcare Research and Quality, the Cecil G. Sheps Center … Read more

Simply closing the Medicare Part D doughnut hole will not be enough to increase cancer patients’ access to oral chemotherapy drugs, according to a new analysis from the UNC Eshelman School of Pharmacy. The drugs are just too expensive at … Read more

Rheumatoid arthritis is autoimmune disease that affects the entire body. People with RA are almost twice as likely as the average person to die from a heart attack and are nine times more likely to develop a serious lung disease. … Read more